Loading...
FRESENIUS KABI DEUTSCHLAND GMBH — Etoposide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #3 buyer for Etoposide · $471.8K import value · 22 shipments · GERMANY · DGFT Verified
FRESENIUS KABI DEUTSCHLAND GMBH is the #3 importer of Etoposide from India with $471.8K in import value and 22 verified shipments. FRESENIUS KABI DEUTSCHLAND GMBH holds a 4.4% market share in Etoposide imports based in GERMANY. The company sources from 1 verified supplier across 18 formulations shipped to 1 country. Overall, FRESENIUS KABI DEUTSCHLAND GMBH imports 10 pharmaceutical products worth $65.5M across 2 therapeutic categories.
Verified from 22 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $471.8K | 22 | 100.0% |
FRESENIUS KABI DEUTSCHLAND GMBH sources Etoposide from 1 verified Indian supplier based on 22 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $1.5M | 34 | $44.7K |
| 3 | FRESENIUS KABI DEUTSCHLAND GMBH ★ | GERMANY | $475.0K | 22 | $21.6K |
| 2 | AMERISOURCE HEALTH SERVICES | UNITED STATES | $350.0K | 7 | $50.0K |
| 4 | EVERSANA LIFE SCIENCES SERVICES LLC | UNITED STATES | $344.7K | 10 | $34.5K |
FRESENIUS KABI DEUTSCHLAND GMBH ranks #3 among 598 Etoposide importers from India. Average shipment value of $21.6K compared to the market average of $7.8K. The closest competitors by value are EVERSANA LIFE SCIENCES SERVICES,LLC and AMERISOURCE HEALTH SERVICES.
Destination countries from 22 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $471.8K | 22 | 100.0% |
FRESENIUS KABI DEUTSCHLAND GMBH imports Etoposide to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $471.8K.
| Formulation | Value | Shipments |
|---|---|---|
| ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87250041AC, MFG. DT. 02/2025, EXP. DT.01/2027 | $63.2K | 2 |
| ETOPOSIDE-KABI (ETOPOSIDE) INJ. 100MG/5ML VIAL BATCH NO.87230346AA, MFG. DT. 07/2023, EXP. DT. 06/2025NOS | $55.1K | 3 |
| ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87230537AA MFG. DT. 12/2023 EXP. DT.11/2025NOS | $50.0K | 1 |
| ETOPOSIDE INJ. 100MG/5ML VIAL, BATCH NO.87240153AA, MFG. DT. 04/2024, EXP. DT.03/2026 | $50.0K | 1 |
| ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87230429AA MANUFACTURING . DT. 09/2023 EXP. DT.08/2025 | $44.9K | 1 |
| ETOPOSIDE KABI INJ. 500MG/25ML VIAL BATCH NO. 87240092AA, MFG. DT. 02/2024, EXP. DT. 01/2026 | $31.6K | 1 |
| ETOPOSIDE KABI INJ 500MG 25ML VIAL BATCH NO 87250129AB MFG DT 04 2025 EXP DT 03 2027 | $25.4K | 1 |
| ETOPOSIDE KABI INJ 500MG 25ML VIAL BATCH NO 87250129AA MFG DT 04 2025 EXP DT 03 2027 |
What FRESENIUS KABI DEUTSCHLAND GMBH and other importers must comply with to import Etoposide from India
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
India exported $4.7M worth of Etoposide through 2,129 shipments from 237 suppliers to 122 countries, serving 598 buyers globally. FRESENIUS KABI DEUTSCHLAND GMBH imports $471.8K of this total, accounting for 4.4% of India's Etoposide exports with 22 shipments from GERMANY. This is verified from 22 customs shipment records covering 18 distinct formulations.
FRESENIUS KABI DEUTSCHLAND GMBH's average Etoposide order value is $21.4K per consignment, based on 22 shipments totaling $471.8K. FRESENIUS KABI DEUTSCHLAND GMBH is based in GERMANY and ranks #3 among all Etoposide importers from India by value. The company sources from 1 verified supplier in India.
FRESENIUS KABI DEUTSCHLAND GMBH sources Etoposide from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($471.8K, 100.0%). This is based on 22 customs records.
FRESENIUS KABI DEUTSCHLAND GMBH ranks #3 among 598 Etoposide importers from India with a 4.4% market share. The top 3 importers are EVERSANA LIFE SCIENCES SERVICES,LLC ($1.5M), FRESENIUS KABI DEUTSCHLAND GMBH ($475.0K), AMERISOURCE HEALTH SERVICES ($350.0K). FRESENIUS KABI DEUTSCHLAND GMBH processed 22 shipments from GERMANY.
FRESENIUS KABI DEUTSCHLAND GMBH also imports these oncology products. Each links to the detailed product page.
FRESENIUS KABI DEUTSCHLAND GMBH imports 10 products worth $65.5M. Beyond Etoposide, top products include Paclitaxel, Carboplatin, Oxaliplatin, Pemetrexed, Irinotecan. View the complete FRESENIUS KABI DEUTSCHLAND GMBH profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Etoposide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI DEUTSCHLAND GMBH's Etoposide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI DEUTSCHLAND GMBH
Full Company Profile →
10 products · $65.5M total trade · 2 categories
| $24.2K |
| 1 |
| ETOPOSIDE INJ. 200MG/10ML VIAL BATCH NO. | $22.8K | 1 |
| ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO. | $21.7K | 1 |
FRESENIUS KABI DEUTSCHLAND GMBH imports 18 distinct Etoposide formulations from India. The top formulation is ETOPOSIDE INJ. 100MG/5ML VIAL BATCH NO.87250041AC, MFG. DT. with 2 shipments worth $63.2K.
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 598+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI DEUTSCHLAND GMBH.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Etoposide. For current order-level data, contact TransData Nexus.